Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alterity, Antengene, Astellas, Astrazeneca, Beigene, Biogen, Daiichi Sankyo, Eisai, Enlivex, Everest, Glaxosmithkline, I-Mab, J&J, Karyopharm, Laurent, Medicago, Moderna, Novavax, Paratek, Pfizer, Seagen, Senhwa, Sobi, Takeda, Tonix, Vir, Zai.